ADORA2A and adenocarcinoma: In this study, we investigated the expression profiles of CD73 and A2AR in tumor cells and found that both proteins were more strongly expressed in adenocarcinoma, particularly TTF-1-positive and EGFR-mutant adenocarcinomas.